Please enable Javascript
Rebecca Araujo
Articles by Rebecca Araujo
ADHD Medication Use Associated With Increased Risk of Hypertension, Arterial Disease
Rebecca Araujo
Hypertension
|
November 30, 2023
The use of ADHD medications may be linked to an increased risk of cardiovascular disease.
Read More
Are CVD Risk Factors Associated With Rheumatoid Arthritis Treatment Failure?
Rebecca Araujo
Rheumatoid Arthritis
|
November 27, 2023
Having multiple risk factors for cardiovascular disease may increase the risk of rheumatoid arthritis treatment failure.
Read More
Evaluating First-line Dostarlimab Versus Pembrolizumab With Chemotherapy in mNSCLC
Rebecca Araujo
Non-Small Cell Lung Cancer
|
November 17, 2023
In patients with metastatic nonsquamous NSCLC, pembrolizumab plus chemotherapy showed clinical efficacy.
Read More
Accelerated Epirubicin After Breast Cancer Excision Linked to Lower QOL During Treatment
Rebecca Araujo
Breast Cancer
|
November 16, 2023
For patients with breast cancer, a regimen of epirubicin followed by adjuvant chemotherapy is associated with worse QOL.
Read More
Brexpiprazole Reduces Agitation in Patients With Dementia Due to Alzheimer Disease
Rebecca Araujo
Dementia
|
November 15, 2023
Treatment with brexpiprazole led to a significant improvement in agitation for patients with dementia due to AD.
Read More
Ranking Psychotherapies for Reducing Generalized Anxiety Disorder Symptoms
Rebecca Araujo
Mental Health
|
November 10, 2023
A study evaluated the efficacy of psychotherapies for the treatment of generalized anxiety disorder in adults.
Read More
Reduced Use of Tofacitinib for US Veterans With RA, Cardiovascular Comorbidities
Rebecca Araujo
Rheumatoid Arthritis
|
November 9, 2023
Recent safety data significantly impacted prescribing practices for advanced RA therapies among physicians treating veterans.
Read More
Younger Age at Diagnosis Is Not Related to ADHD Persistence Over Time
Rebecca Araujo
ADHD
|
November 6, 2023
Younger children with ADHD aren't more likely to have their diagnosis disconfirmed over time than children diagnosed older.
Read More
Assessing Lupus Nephritis Remission Rates After Use of Immunosuppressive Agent Combinations
Rebecca Araujo
Rheumatology
|
November 3, 2023
For adults with lupus nephritis, this specific treatment combination improves total remission rate better than others.
Read More
Pediatricians Report Barriers That Impact Depression Screening in Adolescents
Rebecca Araujo
Depression
|
October 27, 2023
Barriers persist in the implementation of universal routine screening for major depressive disorder in adolescents.
Read More
Adjuvant Atezolizumab Plus Bevacizumab Improves Survival in HCC
Rebecca Araujo
Hepatocellular Carcinoma
|
October 25, 2023
Atezolizumab plus bevacizumab improves recurrence-free survival in patients with resected or ablated high-risk HCC.
Read More
An Effective Treatment for Axial Spondyloarthritis
Rebecca Araujo
Rheumatology
|
October 24, 2023
Bimekizumab demonstrated sustained efficacy for the treatment of active axial spondyloarthritis through 52 weeks.
Read More
Randomized Trial Evaluates Novel Potassium Channel Opener for Focal Epilepsy
Rebecca Araujo
Epilepsy
|
October 20, 2023
A novel potassium channel opener was well-tolerated and reduced seizures in patients with focal-onset seizures.
Read More
Addition of ICIs to Regimen of TACE Plus TKIs Demonstrates Promising Efficacy in HCC
Rebecca Araujo
Hepatocellular Carcinoma
|
October 19, 2023
TACE in combination with TKIs and ICIs led to improvements in response and survival in patients with HCC.
Read More
Angiogenesis Mediators Associated With TACE Response in Hepatocellular Carcinoma
Rebecca Araujo
Unresectable HCC
|
October 5, 2023
A study sought to understand the prognostic ability of 2 angiogenesis mediators to predict poor response to TACE in HCC.
Read More
Identifying Predictors of Hypertrophy After Radiotherapy for Metastatic Liver Cancer
Rebecca Araujo
Unresectable HCC
|
October 5, 2023
A study evaluated predictors of liver segmental hypertrophy following radiotherapy for metastatic liver cancer.
Read More
Favorable Outcomes With TKI Plus Iodine-125 Seed Brachytherapy in TACE-Refractory Liver Cancer
Rebecca Araujo
Unresectable HCC
|
October 5, 2023
A treatment combination significantly improved survival for the treatment of HCC in patients who are refractory to TACE.
Read More
Analyzing Response to HER2-Targeted Regimens in Metastatic Colorectal Cancer
Rebecca Araujo
Colorectal Cancer
|
October 3, 2023
A study evaluated 6 clinical trials of HER2-targeted regimens of HER2-positive metastatic colorectal cancer.
Read More
Impact of Adjuvant Treatment on Liver Cancer Recurrence After Curative Resection
Rebecca Araujo
Hepatocellular Carcinoma
|
September 25, 2023
A study assessed the efficacy of of several adjuvant therapies for hepatocellular carcinoma.
Read More
Real-world Study: Addition of Anti-VEGF to First-line FOLFOX in Metastatic CRC
Rebecca Araujo
Colorectal Cancer
|
September 22, 2023
A study assessed whether the addition of anti-VEGF agent to first-line treatment impacted outcomes in metastatic CRC.
Read More
Load More